Allopath Pharmaceuticals India Private Limited
About Allopath Pharmaceuticals India Private Limited
Data last updated:
Allopath Pharmaceuticals India Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 05 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239HR2019PTC081328. Its GSTIN is 06AASCA4800F1ZU (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Darshana Katyal and Dheeraj Katyal.
Its last annual general meeting (AGM) was held on 08 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 8/8 First Floor Ardee City Sector 52, Gurgaon, Haryana, India – 122002.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.08 Lakh, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Lakh (net margin 2.4%) and EBITDA of ₹2.32 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
Company details
Contact details
Allopath Pharmaceuticals India Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 8/8 First Floor Ardee City Sector 52, Gurgaon, Haryana, India – 122002
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Allopath Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Allopath Pharmaceuticals India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Allopath Pharmaceuticals India Private Limited, buy the company report.
Financials of Allopath Pharmaceuticals India Private Limited
FY 2025 filings availableAllopath Pharmaceuticals India Private Limited reported revenue of ₹64.08 Lakh (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Allopath Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Allopath Pharmaceuticals India Private Limited
Allopath Pharmaceuticals India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Darshana Katyal | Director | 05 Jul 2019 | 7 Years 4 Months | Current |
| Dheeraj Katyal | Director | 05 Jul 2019 | 7 Years 4 Months | Current |
Peer comparison
Allopath Pharmaceuticals India Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M.T Pharmaceuticals Private Limited | ₹64.22 Lakh (FY 2025) | -24.0% | Gorakhpur, Uttar Pradesh, India | |||
| Verum Pharmaceuticals Private Limited | ₹64.16 Lakh (FY 2025) | 15.0% | Silchar, Assam, India | |||
| Allopath Pharmaceuticals India Private Limitedthis company | ₹64.08 Lakh (FY 2025) | ₹1.51 Lakh | 2.4% | -9.0% | Gurgaon, Haryana, India | |
| Venemed Pharmaceuticals Private Limited | ₹64.08 Lakh (FY 2025) | 884.0% | Delhi, India |
To see the full peer comparison of Allopath Pharmaceuticals India Private Limited, buy the company report.
Auditor
Allopath Pharmaceuticals India Private Limited is audited by SUBHASH CHAND & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUBHASH CHAND & ASSOCIATES | FY 2022 | 032185N |
Shareholding
The shareholding of Allopath Pharmaceuticals India Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Allopath Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Allopath Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Allopath Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Allopath Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AASCA4800F1ZU | Haryana | Active | 25 Jul 2019 |
To see the full GST registrations and return filing status of Allopath Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Allopath Pharmaceuticals India Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Neeraj Chauhan ceased to be Director on 19 Dec 2024.
Frequently asked questions
Allopath Pharmaceuticals India is an active private limited company based in Gurgaon, Haryana, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 05 July 2019 (7+ years old) and is registered under CIN U24239HR2019PTC081328.
Allopath Pharmaceuticals India has 2 current directors:
- Darshana Katyal - Director
- Dheeraj Katyal - Director
The latest financial statements of Allopath Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 October 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Allopath Pharmaceuticals India is 06AASCA4800F1ZU, registered in Haryana.
The CIN (Corporate Identification Number) of Allopath Pharmaceuticals India is U24239HR2019PTC081328. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Allopath Pharmaceuticals India was incorporated on 05 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Allopath Pharmaceuticals India by revenue are M.T Pharmaceuticals Private Limited, Verum Pharmaceuticals Private Limited, Venemed Pharmaceuticals Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Neeraj Chauhan ceased to be Director on 19 Dec 2024. Darshana Katyal ceased to be Director on 18 Dec 2024. Darshana Katyal was appointed as Director on 05 Jul 2019. Allopath Pharmaceuticals India has 4 board changes on record in total.
The registered office of Allopath Pharmaceuticals India is at C – 88 First Floor Ardee City Sector 52, Gurgaon, Haryana, India – 122002.
Allopath Pharmaceuticals India operates in the healthcare industry, in the ayurvedic products and services segment.
Allopath Pharmaceuticals India can be reached at its registered office: C – 88 First Floor Ardee City Sector 52, Gurgaon, Haryana, India – 122002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
